Component information
No US or EU label exists for this exact combination, so information is shown for each component.
Use: Uses For the temporary relief of pain and itching associated with: insect bites minor cuts minor burns sunburn scrapes minor skin irritations rashes due to poison ivy, poison oak, or poison sumac US FDA label
- capsisum no separate page
Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.
Dosing: Altered kidney function
No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.
Kidney dosing for each component (single-agent) is shown under Component information.
Kidney-specific guidance from renalcarematters.com: in preparation.
Dosage forms
Philippines
- Oral solution: 1.75 mL/1.20 mL/0.2 g per 100 mL
Registered products in the Philippines
1 product registered with the Food and Drug Administration (FDA) Philippines list Camphor + Capsisum + Clove oil as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.
| Package insert | |||||||
|---|---|---|---|---|---|---|---|
NoneCapsisum + Clove oil + Camphor | 1.75 mL/ 1.20 mL/ 0.2 g per 100 mL Oral SolutionAmber Bottle x 7.5 mL | OTC | Dann's Aid Lab Inc.Philippines | — | HRP-557 | Jul 24, 2031 |
Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.
Formulary and pricing (Philippines)
Check availability
Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.
References
- Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.
Last updated: .